A comprehensive prenatal genetic test that combines Chromosomal Microarray Analysis (CMA) and Rapid Clinical Exome Sequencing (CES) to identify chromosomal abnormalities and gene mutations in the fetus. Maternal Cell Contamination (MCC) testing is included to ensure the accuracy and reliability of fetal DNA analysis. Chromosomal microarray detects copy number changes such as microdeletions and microduplications, while rapid exome sequencing identifies disease-causing variants in the protein-coding regions of genes.
Why is this test done?
Detects chromosomal abnormalities and pathogenic gene variants in the fetus
Investigates abnormal fetal ultrasound findings
Evaluates pregnancies with suspected genetic disorders
Helps diagnose developmental and congenital abnormalities
Supports informed pregnancy management and genetic counseling
Provides rapid results in time-sensitive prenatal cases
Who should consider this test?
Pregnancies with abnormal ultrasound findings
Couples with a previous child affected by a genetic disorder
Families with a history of inherited diseases
Cases with inconclusive routine prenatal genetic tests